1. Home
  2. SUPN vs AERO Comparison

SUPN vs AERO Comparison

Compare SUPN & AERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.15

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

AERO

Grupo Aeromexico S.A.B.

HOLD

Current Price

$15.61

Market Cap

2.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
AERO
Founded
2005
1934
Country
United States
Mexico
Employees
N/A
17068
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
SUPN
AERO
Price
$48.15
$15.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$61.60
$28.57
AVG Volume (30 Days)
916.2K
287.8K
Earning Date
05-05-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,755,000.00
N/A
Revenue This Year
$22.70
$11.85
Revenue Next Year
$19.14
$4.57
P/E Ratio
N/A
$7.95
Revenue Growth
N/A
N/A
52 Week Low
$32.21
$12.26
52 Week High
$59.68
$23.05

Technical Indicators

Market Signals
Indicator
SUPN
AERO
Relative Strength Index (RSI) 54.04 37.80
Support Level $47.48 $14.28
Resistance Level $52.24 $17.17
Average True Range (ATR) 1.58 0.77
MACD 0.10 -0.26
Stochastic Oscillator 38.42 18.67

Price Performance

Historical Comparison
SUPN
AERO

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About AERO Grupo Aeromexico S.A.B.

Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.

Share on Social Networks: